DrugsData.org (was EcstasyData): Test Details : Result #16957

- All Test Results
- Test Details
- Advanced Search
- Overview
- How the project is funded

© Copyright 2001-2024 Erowid Center. DrugsData is a project of Erowid Center. All rights reserved.

By using this site you agree not to publish its images, data, results, or analysis of its results without written permission from Erowid Center. Permission is required before using data from DrugsData in any of these ways, including importing it into public or shared databases, software, or systems. This policy has been in place since 2001 in order to require cooperation and credit by researchers and app authors.

Your javascript is turned off. To remove this message, turn on javascript and accept the Terms of Use.

New Submissions Are Not Currently Being Accepted

Samples sent after April 10, 2024 will be put on hold.

Viewing desktop version: Switch to Mobile

Royal Post (NL; bi-layer tablet)

Sold as: MDMA / Ecstasy

ID: 16957

ID:	16957
Name:	Royal Post
Other Names:	NL; bi-layer tablet
HPLC:The HPLC Lab Test
MDMA : 261.10 mg MDMA aka Ecstasy, E, X

Test Date:	Jun 10, 2023
Pub. Date:	Aug 22, 2023
Src Location:	Geneva, Switzerland
Submitter Loc:	Geneva, -- Switzerland
Color:	Blue / Yellow
Size:	434.8 mg, 10.10 mm x 12.10 mm x 9.3 mm
Data Source:	SaferParty.ch
Tested by:	Mobile Unit
Lab's ID:	SP:202308-34

Sold as: MDMA / Ecstasy

Expected to be: Not Specified

Warning

The European drug checking group that analyzed this tablet issued an extreme high dose warning for it, stipulating that 1.3 milligrams MDMA per kilogram of body weight in women and 1.5 milligrams of MDMA per kilogram of body weight in men should not be exceeded.

Analyzed by SaferParty (Switzerland) in June 2023.

Send in a sample for testing

DrugsData tests all psychoactive drugs including ecstasy tablets, powders, research chemicals, novel pschoactive substances, and other drugs through our licensed laboratory. Ecstasy/Molly tablets cost $100. Recreational drug powder/crystal/blotter costs $100. Pharmaceuticals, supplements and all others cost $150 per analysis.

Learn more

Support DrugsData

Should the public have access to independent analysis of the products they consume?

The vast majority of analyses of over-the-counter, prescription, and recreational drugs are performed in secret with no independent oversite or review. No other historical record, free from politically-controlled agencies, is currently available in North America nor most other parts of the world.

DrugsData, a project of Erowid Center, needs the support of professionals, students, parents, individuals with means, and small foundations for a total yearly budget of around $120,000 USD. Erowid Center's general budget and the co-pays we require fund most of this cost.

Donate now

Search Lab Results by	Advanced Search